BioSpace News Archive

Organovo Holdings, Inc. (NASDAQ: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate key aspects of human disease, today announced that Keith Murphy, Executive Chairman, will participate in the H.C. Wainwright 24th Annual Global Investment Conference.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced development updates for its novel asthma and allergy maintenance therapeutic, HT-004.

Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will present a corporate overview at the 24th Annual H.C. Wainwright Global Investment Conference.

Pain Specialists of America is pleased to announce that Jacob Caylor, MD, DABA, has joined their team to provide patient care in the rapidly growing Cedar Park and Round Rock markets of the North Austin region in Texas.

Dermata Therapeutics, Inc. announced that Gerry Proehl, Dermata’s Chairman of the Board, President, and Chief Executive Officer will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022.

Curavit Clinical Research, a virtual contract research organization (VCRO), has entered into a long-term partnership with ixlayer to provide easy access to clinical-grade diagnostic lab testing for decentralized clinical trials (DCTs).

ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most advanced next generation pertussis vaccine, today announced the closing of a $42.8 million Class D round of financing.

Tricida, Inc. announced that it will present at the H.C. Wainwright 24th Annual Global Investment Conference. Tricida will provide a company overview, business update and progress on the company’s key initiatives.

Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of Charlottesville Medical Research, a community-based research facility based in Charlottesville, Virginia.

Hemophilia, a group of common hemorrhagic inherited disorders, that interferes with normal blood coagulation.